Epithelial–mesenchymal transition (EMT) is a cell remodeling process in which epithelial
cells undergo a reversible phenotype switch via the loss of adhesion capacity and …

Metastasis and drug resistance are the leading causes of death for breast cancer patients.
Epithelial–mesenchymal transition (EMT), a transition from polarized epithelial cells to motile …

Breast carcinoma is highly metastatic and invasive. Tumor metastasis is a convoluted and
multistep process involving tumor cell disseminating from their primary site and migrating to …

The epithelial-mesenchymal transition (EMT) represents a biological program during which
epithelial cells lose their cell identity and acquire a mesenchymal phenotype. EMT is …

Simple Summary Epithelial-to-mesenchymal transition (EMT) is a cellular program that
enables epithelial cells to transition toward a mesenchymal phenotype with augmented …

Breast cancer is a highly complex tissue composed of neoplastic and stromal cells.
Carcinoma-associated fibroblasts (CAFs) are commonly found in the cancer stroma, where …

Breast cancer is the most common cancer in women and distant site metastasis is the main
cause of death in breast cancer patients. There is increasing evidence supporting the role of …

Epithelial–mesenchymal transition (EMT) induces invasive properties in epithelial tumors
and promotes metastasis. Although EMT-mediated cellular and molecular changes are well …

Within heterogeneous tumors, cancer stem cell (CSC) populations exhibit the greatest tumor
initiation potential, promote metastasis, and contribute to therapy resistance. For breast …

Background Epithelial–mesenchymal transition (EMT) is often linked with carcinogenesis.
However, EMT is also important for embryo development and only reactivates in cancer …